DavidJAdelsteinMD

Co-Chairman, National Cancer Institute Head and Neck Cancer Steering Committee, Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Join to view full profile

Dr. Adelstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Adelstein's full profile

Already have an account?

Office
9500 Euclid Ave
Desk R-35
Cleveland, OH 44195
Phone+1 800-223-2273

Fax+1 216-444-9464

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1978 - 1981
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1975 - 1979
New York University School of MedicineClass of 1975
University of ChicagoB.A., 1968 - 1971

Certifications & Licensure

OH State Medical License 1977 - 2025
MI State Medical License 1990 - 1991
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Directors Service Award National Cancer Institute, 2011, 2013
Teacher of the Year: Department of Solid Tumor Oncology Taussig Cancer Institute, Cleveland Clinic, 2009-2010
Teacher of the Year: Department of Hematology and Medical Oncology Cleveland Clinic Foundation, 2001-2002
Alpha Omega Alpha 1974
University Scholar University of Chicago, 1968-1971
America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2008-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2003 Apr 01
Completed
Phase 2
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer Start of enrollment: 2005 Oct 01
Completed
Phase 2
S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx Start of enrollment: 2005 Dec 01
Terminated
Phase 3
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma Start of enrollment: 2002 Aug 01
Completed
Phase 2
Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach Start of enrollment: 2008 Jan 05
Completed
Phase 2
Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2008 Jan 01
Completed
Phase 3
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery Start of enrollment: 2011 Jan 01
Active, not recruiting
Phase 2
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer Start of enrollment: 2010 Oct 28
Completed
Phase 2
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Start of enrollment: 2011 Jun 01
Active, not recruiting
Phase 3
Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ) Start of enrollment: 2011 Aug 01
Terminated
Phase 1, Phase 2
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22
Recruiting
Phase 2, Phase 3
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

718 citations
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma
Thomas P. Miller, Steve Dahlberg, J. Robert Cassady, David J. Adelstein, Catherine M. Spier
The New England Journal of Medicine. 1998-07-02
470 citations
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICO...
Brian O'Sullivan, Shao Hui Huang, Jie Su, Adam S. Garden, Erich M. Sturgis
The Lancet. Oncology. 2016-04-01
76 citations
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
Remco J. Molenaar, Surbhi Sidana, Tomas Radivoyevitch, Anjali S. Advani, Aaron T. Gerds
Journal of Clinical Oncology. 2017-12-18

Journal Articles

Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and Toxicity
Brian B Burkey, Neil M Woody, John F Greskovich, David J Adelstein, Aditya Juloori, Shlomo A Koyfman, Joseph Scharpf, Brandon Prendes, Anticancer Research
Its not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy
Naik M, Ward MC, Bledsoe TJ, Kumar AMS, Rybicki LA, Saxton JP, Burkey BB, Greskovich JF, Koyfman SA, Oral Oncology, 1/1/2016
Prospective clinical study of precision oncology in solid tumors
Sohal DPS, Rini BI, Khorana AA, Dreicer R, Abraham J, Procop GW, Saunthararajah Y, Pennell NA, Stevenson JP, Pelley R, Estfan B, Shepard D, Funchain P, Elson P, Adelst..., Journal of the National Cancer Institute, 1/1/2016
Current status of clinical trials in head and neck cancer 2014
Liu JC, Ridge JA, Brizel DM, O’Sullivan B, Cohen EW, Mann BS, Otolaryngology Head and Neck Surgery, 1/1/2015
Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy
Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Burkey BB, JAMA Otolaryngology Head and Neck Surgery, 1/1/2015
Oncologic and functional outcomes of surgical and non-surgical treatment for advanced squamous cell carcinoma of the supraglottic larynx
Elegbede AI, Rybicki LA, Kaltenbach JA, Lorenz RR, Scharpf J, Burkey BB, JAMA Otolaryngology Head and Neck Surgery, 1/1/2015
Pharmacotherapy of head and neck cancer
Nwizu T, Adelstein D, Expert Opinion on Pharmacotherapy, 1/1/2015
The impact of feeding tube choice on severe late dysphagia after definitive chemoradiation for HPV negative head and neck cancer
Ward MC, Bhateja P, Nwizu T, Kmiecik J, Reddy CA, Scharpf J, Lamarre ED, Burkey BB, Greskovich JF, Koyfman SA, Head and Neck, 1/1/2015
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma...
McNamara MJ, Rybicki LA, Sohal D, Allende DS, Videtic GMM, Rodriguez CP, Stephans KL, Murthy SC, Raja S, Raymond D, Ives DI, Bodmann JW, Journal of Gastrointestinal Oncology, 1/1/2015
First site of failure analysis incompletely addresses issues of late and unexpected metastases in p16 positive oropharyngeal cancer
O Sullivan B, Huang SH, Koyfman S, Thorstad W, Hope A, Lewis JS, Nussenbaum B, Journal of Clinical Oncology, 1/1/2015
Solitary dural metastasis at presentation in a patient with untreated human papillomavirus associated squamous cell carcinoma of the oropharynx
Al Khudari S, Guo S, Chen Y, Nwizu T, Greskovich JF, Lorenz R, Burkey BB, Koyfman SA, Head and Neck, 1/1/2014
A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil followed by surgery and post-operative concurrent cisplatin and fluorouracil chemo-radiotherap...
McNamara MJ, Rice TW, Rybicki LA, Rodriguez CP, Videtic GMM, Saxton JP, Stephans KL, Greskovich JF, Sohal D, Mason DP, Murthy SC, Ives DI, Bodmann JW, Journal of Thoracic Oncology, 1/1/2014
Impact of intensity-modulated radiation therapy on outcomes for malignant pleural mesothelioma treated with trimodality therapy
Murphy ES, Adelstein DJ, Murthy SC, Rice TW, Mason DP, Vassil NN, Reddy CA, Vassil AD, Videtic GMM, Journal of Radiation Oncology, 1/1/2014
In squamous cell head and neck cancer: Which platinum, how much and how often
Nwizu T, Adelstein DJ, Expert Reviews of Anticancer Therapy, 1/1/2014
Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: A retrospective analysis of two clinical trials
Sohal DPS, Rice TW, Rybicki LA, Rodriguez CP, Videtic GMM, Saxton JP, Murthy SC, Mason DP, Phillips BE, Tubbs RR, Plesec T, McNamara MJ, Ives DI, Bodmann JW, Diseases of the Esophagus, 1/1/2014
A randomized phase III study of two cisplatin based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: The impact of changing disease ...
Rodriguez CP, Rybicki LA, Savvides P, Saxton JP, Koyfman SA, Greskovich JF, Yao M, Scharpf J, Lavertu P, Wood BG, Burkey BB, Lorenz RR, Rezaee RP, Zender CA, Ives DI, Head and Neck, 1/1/2014
Predictive value of clinical factors through restaging after induction concurrent chemoradiotherapy for locoregionally advanced adenocarcinoma of the esophagus and gas...
Phillips B, Rice T, Rybicki L, Rodriguez C, Videtic G, Saxton J, Murthy S, Mason D, Ives D, Journal of Solid Tumors, 1/1/2013
Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2 positive adenocarcinoma of the esophagus and gastroesophage...
Phillips BE, Tubbs RR, Rice TW, Rybicki LA, Plesec T, Rodriguez CP, Videtic GM, Saxton JP, Ives DI, Diseases of the Esophagus, 1/1/2013
Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure
Li M, Lorenz RR, Khan MJ, Burkey BB, Greskovich JF, Koyfman SA, Scharpf J, Otolaryngology Head and Neck Surgery, 1/1/2013
Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: Patterns of failure and toxicity outcomes
Bledsoe TJ, Noble AR, Hunter GK, Rybicki LA, Hoschar A, Chute DJ, Saxton JP, Greskovich JF, Koyfman SA, Radiation Oncology, 1/1/2013
A phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer
Halmos B, Jia Y, Bokar JA, Fu P, Adelstein DJ, Juergens R, Rodal MB, Dowlati A, Investigational New Drugs, 1/1/2013
Induction chemotherapy meta analysis in head and neck cancer: Right answer, wrong question (Editorial)
Forastiere AA, Manola J, Journal of Clinical Oncology, 1/1/2013
Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly
Michal SA, Rybicki LA, Rodriguez CP, Saxton JP, Wood BG, Scharpf J, Ives DI, Head and Neck, 1/1/2012
A single arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck
Rodriguez CP, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Scharpf J, Ives DI, Head and Neck, 1/1/2012
A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
Rodriguez CP, Rybicki LA, Ives DI, Rice TW, Investigational New Drugs, 1/1/2012
Join now to see all

Books/Book Chapters

Sataloff’s Comprehensive Textbook of Otolaryngology
Chapter: Principles of Medical Oncology
Page 45 - 54Rodriguez CP, Adelstein DJEditors: Sataloff R, Gullane PJ, Goldstein DP.Jaypee Brothers Ltd2015
Cancer Consult: Expertise for Clinical Practice
Chapter: Medical management of head and neck cancers
Page 467 - 475Nwizu T, Adelstein DJEditors: Abutalib SA, Markman M.John Wiley & Sons, Inc.2014
Perez and Bradys Principles and Practice of Radiation Oncology
Chapter: Locally advanced squamous carcinoma of the head and neck
Page 718 - 729Brizel DM, Adelstein DJEditors: Halperin EC, Wazer DE, Perez CA, Brady LW.Lippincott Williams & WilkinsEdition 6th,2013
Head and Neck Cancer: Multimodality Management
Chapter: Principles of systemic chemotherapy for squamous cell head and neck cancer.
Page 281 - 291Rodriguez CP, Adelstein DJEditors: Bernier J.Bernier JEdition 1st,2011
Current Clinical Medicine 2010
Chapter: Head and Neck Cancer
Page 654 - 656Rodriguez CP, Adelstein DJEditors: Carey WD.Saunders ElsevierEdition 2nd,2010
Head and Neck Surgery
Chapter: Principles of combining chemotherapy with radiation therapy in advanced squamous cell head and neck cancer
Page 819 - 831Adelstein DJEditors: de Souza C, Har-El G, Stucker F, Nathan CAO, D'Cruz A, Chaturvedi P, Bhattacharyya AK.Jaypee Brothers LtdEdition 1st,2009
Current Clinical Medicine 2009
Chapter: Esophageal Cancer
Page 633 - 638Absi A, Adelstein DJ, Rice TEditors: Carey WD.Saunders ElsevierEdition 1st,2009
Pearson’s Thoracic and Esophageal Surgery
Chapter: Definitive management of inoperable non-small cell lung cancer
Page 804 - 821Adelstein DJ, Videtic GMM, Mekhail TEditors: Patterson GA, Cooper JD, Deslauriers J, Lerut AEMR, Luketich JD, Rice TW.Churchill Livingstone ElsevierEdition 3rd,2008
Options in the Treatment of Head and Neck Cancer
Chapter: Integration of chemotherapy into organ preservation strategies for squamous cell head and neck cancer
Page 77 - 90Adelstein DJEditors: Integration of chemotherapy into organ preservation strategies for squamous cell head and neck cancer.CMP Medica2006
Cleveland Clinic Disease Management Project
Chapter: Esophageal Cancer
Absi A, Adelstein DJThe Cleveland Clinic Foundation2005
Squamous Cell Head and Neck Cancer: Recent Clinical Progress and Prospects for the Future
Chapter: Concurrent chemoradiotherapy: Impact on survival and organ preservation
Page 187 - 195Adelstein DJEditors: Adelstein DJ.Humana Press2005
Squamous Cell Head and Neck Cancer: Recent Clinical Progress and Prospects for the Future
Adelstein DJHumana Press, Totowa, NJ2005
Principles and Practice of Head and Neck Oncology
Chapter: Chemotherapy for head and neck cancer
Page 79 - 98Saini A, Gore ME, Adelstein DJEditors: Rhys Evans PH, Montgomery PQ, Gullane PJ.Rhys Evans PH, Montgomery PQ, Gullane PJ2003
Head and Neck Cancer: Emerging Perspectives
Chapter: Clinical trials in advanced unresectable head and neck cancer
Page 461 - 474Adelstein DJEditors: Ensley JF, Gutkind JS, Jacobs JR, Lippman SM.Academic Press2003
American Society of Clinical Oncology Education Book
Chapter: Oropharyngeal cancer: The role of the medical oncologist in organ-function conservation
Page 544 - 550Adelstein DJEditors: Perry MC.American Society of Clinical Oncology, Alexandria1999
Cleveland Clinic Intensive Review of Internal Medicine
Chapter: Oncologic emergencies
Page 193 - 200Adelstein DJEditors: Stoller JK, Ahmad M, Longworth DL.Williams and WilkinsEdition 1st,1998
Medicine for the Practicing Physician
Chapter: Hairy cell leukemia.
Page 881 - 883Adelstein DJEditors: Hurst JW.Appleton and LangeEdition 4th,1996
The High Risk Patient: Management of the Critically Ill
Chapter: Oncologic toxicities and emergencies.
Page 866 - 898Adelstein DJ, Lichtin AEEditors: Sivak ED, Higgins TL, Seiver A.Williams and Wilkins1995
Pocket Manual of Differential Diagnosis
Chapter: Hematologic System
Page 197 - 222Adelstein DJEditors: Adler SN, Lam M, Gasbarra DB, Connors AF.Little, Brown and Co.Edition 2nd,1988
Primary Care of Cancer
Chapter: Cancer of the head and neck.
Page 53 - 58Adelstein DJEditors: Mortimer EA Jr..Case Western Reserve University School of Medicine, Cleveland, OH1987
Join now to see all

Abstracts/Posters

Measuring impact of survivorship care plans on head and neck cancer patients
Harr BA, Bodmann J, Koyfman SA, Nwizu TI, Joshi NP, Ives DI, Rahe ML, Hamker JF, Journal of Clinical Oncology, 1/1/2016
Pathologic and clinical outcomes in cT2N0 esophageal cancer: A cohort study
Bhuchar G, Altujjar M, Raja S, Murthy SC, Raymond D, Videtic GMM, McNamara MJ, Khorana AA, Sohal D, Journal of Clinical Oncology, 1/1/2016
The impact of persistent dysphagia (PD) after induction chemotherapy in patients with loco-regionally advanced (LRA) adenocarcinoma (ACA) of the esophagus and gastro-e...
McNamara MJ, Rybicki LA, Rodriguez CP, Videtic GMM, Stephans KL, Greskovich J, Sohal D, Murthy SC, Raja S, Ives DI, Bodmann J, Journal of Clinical Oncology, 1/1/2015
The relationship between pathologic nodal disease and residual tumor viability (RV) in patients with loco regionally advanced (LRA) adenocarcinoma (ACA) of the esophag...
McNamara MJ, Rybicki LA, Rodriguez CP, Videtic GMM, Stephans KL, Greskovich J,Sohal D, Murthy SC, Raja S, Ives DI, Bodmann J, Journal of Clinical Oncology, 1/1/2015
Prospective clinical study of precision oncology in solid tumors
Sohal D, Rini BI, Khorana AA, Dreicer R, Abraham J, Procop G, Saunthararajah Y, Pennell NA, Stevenson J, Pelley RJ, Estfan BN, Shepard DR, Funchain P, Bolwell BJ, Journal of Clinical Oncology, 1/1/2015
Quality of life (QOL) as a predictor of clinical outcome in patients (pts) with head and neck cancer (HNC)
Sendilnathan A, Deeb A, Bach R, Agarwal R, Xie C, Kaval F, Robinson C, Guthrie K, Dupuy S, Wise-Draper TM, Morris JC, Mierzwa ML, Huth BJ, Redmond KP, Barrett W, Patil..., Journal of Clinical Oncology, 1/1/2015
Retrospective analysis of benefit from concurrent chemoradiotherapy (CRT) in high risk squamous cell carcinoma of the oral cavity (SCC OC)
Varella LBF, Noble AR, Koyfman SA, Reddy CA, Greskovich J, Nwizu TI, Burkey B, Scharpf J, Khan M, Lorenz R, Lamarre E, Journal of Clinical Oncology, 1/1/2015
Cetuximab based bioradiation therapy is associated with higher rates of distant metastases than platinum based chemoradiation therapy in human papillomavirus positive ...
Weller MA, Ward MC, Berriochoa CA, Reddy CA, Trosman S, Greskovich JF, Nwizu T, Burkey BB,, International Journal of Radiation Oncology, Biology, Physics, 1/1/2015
Severe late dysphagia and cause of death after concurrent chemoradiation therapy for larynx cancer in patients eligible for RTOG 91 11
Ward MC, Bhateja P, Houston N, Nwizu T, Scharpf J, Lorenz R, Burkey BB, Greskovich JF, Koyfman S, International Journal of Radiation Oncology, Biology, Physics, 1/1/2015
Primary tumor factors not lymph node factors are associated with contralateral failure in resected squamous cell carcinoma of the mobile tongue
Woody NM, Noble A, Ward MC, Khan M, Lamarre E, Lorenz R, Scharpf J, Burkey BB, Koyfman S, International Journal of Radiation Oncology, Biology, Physics, 1/1/2015
A safety and efficacy comparison of high dose definitive (more than 70 Gy) versus postoperative reirradiation using Intensity Modulated Radiation Therapy (IMRT) in rec...
Zakem SJ, Koyfman S, Ward MC, Nwizu T, Reddy CA, Lamarre E, Scharpf J, Burkey BB, Greskovich JF, International Journal of Radiation Oncology, Biology, Physics, 1/1/2015
A comparison of control and toxicity outcomes for conventional versus accelerated fractionation schedules of IMRT based chemoradiation therapy in head and neck cancer
Manyam B, Ward MC, Joshi NP, Noble A, Harr B, Houston N, Nwizu T, Greskovich JF, Koyfman S, International Journal of Radiation Oncology, Biology, Physics, 1/1/2015
Advanced practice nurse follow-up clinic reduces emergency room visits and admissions in high-risk patients after chemoradiation therapy for head and neck cancer
Harr B, Hamker J, Joshi NP, Ward MC, Bodmann J, Ives D, Rahe M, Nwizu T, Greskovich JF, Koyfman S, International Journal of Radiation Oncology, Biology, Physics, 1/1/2015
Distant metastatic failure patterns in squamous cell cancer of the Oropharynx (SCCOP) treated with chemoradiation: the impact of Human Papillomavirus (HPV)
Trosman S, Al-Khudari S, Koyfman SA, Nwizu T, Greskovich JF, Scharpf J, Lamarre E, Khan M, Burkey BB, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Risk factors predictive for poor outcomes in patients with human papillomavirus (HPV) initiated oropharyngeal cancer (OPC)
Nwizu T, Koyfman S, Bledsoe TB, Hyslop E, Reddy CA, Lamarre E, Scharpf J, Burkey BB, Greskovich JF, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Modest late toxicity and excellent quality of life in patients with human papillomavirus (HPV positive) associated oropharyngeal carcinoma treated with Intensity Modul...
Koyfman S, Bledsoe TB, Barnett J, Reddy CA, Nwizu T, Chute D, Saxton JP, Burkey BB, Greskovich JF, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Patterns of failure and factors associated with with disease recurrence in patients with stage III, IV squamous cell carcinoma of the oral cavity (SCC OC) treated wit...
Koyfman SA, Noble A, Han JH, Greskovich JF, Nwizu T, Reddy CA, Khan M, Scharpf J, Burkey BB, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Development of a head and neck cancer survivorship clinic: The Cleveland Clinic experience
Harr BA, Bodmann JW, Koyfman SA, Nwizu TI, Greskovich JF, Hamker JJ, Ives DI, Rahe ML, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Return to work and quality of life after chemoradiotherapy for head and neck cancer
Bodmann JW, Rybicki LA, Harr BA, Ives DI, Koyfman SA, Nwizu TI, Greskovich JF, Rahe ML, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Improving healthcare value in patients with stage III-IVb squamous cell carcinoma of head and neck (HNSCC): Comparative effectiveness of two arms of a randomized, pha...
Greskovich JF, Gordian M, Lorenz R, Scharpf J, Khan M, Burkey B, Ives D, Nwizu T, Koyfman S, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Risk factors predictive for poor outcomes in patients with human papillomavirus (HPV) initiated oropharyngeal cancer
Nwizu TI, Koyfman SA, Bledsoe TB, Hyslop E, Reddy CA, Lamarre E, Scharpf J, Lorenz R, Khan M, Burkey B, Greskovich J, Journal of Clinical Oncology, 1/1/2014
Inferior local control for T2bN0 glottic carcinoma with impaired mobility treated with radiation alone: A need for more chemotherapy
Bhateja P, Ward MC, Greskovich J, Reddy CA, Nwizu TI Koyfman SA, Journal of Clinical Oncology, 1/1/2014
NCI pilot intervention program to assist accrual for challenging late phase clinical trials
Denicoff A, Massett H, Souhan E, Cave, L, Welch JJ, Seibel N, Little RF, Mann BS, Dipiazza K, Hartson-Stine S, Lambersky R, DeSanto F, Fonzi F, Schrag D, Abrams RA, Br..., Journal of Clinical Oncology, 1/1/2014
The impact of 5 fluorouracil (5FU) dose intensity (DI) on survival outcomes in patients (pts) receiving multimodality therapy for locoregionally advanced (LRA) adenoca...
McNamara MJ, Videtic GMM, Sohal D, Rice TW, Rodriguez CP, Saxton JP, Stephans KL, Greskovich J, Mason DP, Murthy SC, Ives DI, Bodmann J, Rybicki LA, Journal of Clinical Oncology, 1/1/2014
Intensity Modulated Radiation Therapy (IMRT) reduces late toxicity in patients with human papillomavirus-associated (HPVpositive) oropharyngeal carcinoma treated with ...
Koyfman S, Bledsoe TB, Barnett J, Reddy CA, Chute D, Nwizu T, Saxton JP, Burkey BB, Greskovich JF, International Journal of Radiation Oncology, Biology, Physics, 1/1/2014
Join now to see all